NEW YORK, Sept. 24, 2018 /PRNewswire/ — MouSensor, Inc., a biotechnology company that develops a novel and potentially transformative platform to digitize the sense of smell, announced today that it has raised $3.3M in its seed round. The seed round was co-led by imec.xpand and Alexandria Venture Investments with participation from New York Ventures and Elma…
Charlotte D’Hulst, CEO of MouSensor, Inc., nominated as one of the top 50 Flemish innovators for the future by Belgian newspaper “De Tijd”.
The Michael J.Fox Foundation for Parkinson’s research awards MouSensor, Inc. with $250K in follow-up funding.
CEO, Charlotte D’Hulst, selected to represent MouSensor, LLC at the annual Women in Bio Plenary Event in San Diego, CA.
MouSensor, LLC won its first NSF SBIR phase I grant ($225,000).
MouSensor, LLC won the Outstanding Pitch Award at the annual NewYorkBIO conference on May 11, 2017.
MouSensor LLC won a grant from the Michael J. Fox Foundation for Parkinson’s Research.
MouSensor, LLC’s co-founder Charlotte D’Hulst was recently featured in EisnerAmper’s 2016-2017 winter issue of Catalyst on women in biotech.
MouSensor, LLC’s story was picked up by the prestigious Belgian newspaper De Tijd (PDF).
The MouSensor technology was covered by Science Magazine.
The paper entitled: “MouSensor: A Versatile Platform to Create Super Sniffer Mice for Studying Human Odor Coding” was published on July 7th, 2016, in Cell Reports. These important proof-of-concept data were generated in the Feinstein Lab for Neurogenetics at Hunter College, CUNY and form the basis for MouSensor, LLC. …
MouSensor, LLC was selected to participate in the prestigious Entrepreneurship Lab program, ELabNYC 2016, which teaches business skills and networks its participants.